Lataa...
Targeting Filarial Abl-like Kinases: Orally Available, Food and Drug Administration–Approved Tyrosine Kinase Inhibitors Are Microfilaricidal and Macrofilaricidal
Background. Elimination of onchocerciasis and lymphatic filariasis is targeted for 2020. Given the coincident Loa loa infections in Central Africa and the potential for drug resistance development, the need for new microfilaricides and macrofilaricides has never been greater. With the genomes of L....
Tallennettuna:
| Julkaisussa: | J Infect Dis |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4539898/ https://ncbi.nlm.nih.gov/pubmed/25657255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiv065 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|